Drug Profile
B cell High Density Microparticles - BioTransplant
Alternative Names: B cell HDM - BioTransplant; B cell-SC cell separation systemLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator BioTransplant (CEASED)
- Class Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Lymphoma
Most Recent Events
- 24 Feb 2004 BioTransplant has ceased operations
- 28 Nov 2003 BioTransplant expects to file with the Bankruptcy Court in the coming weeks
- 28 Nov 2003 Discontinued - Phase-II for Lymphoma in USA (unspecified route)